| Dr Brian J Sullivan, MD | |
|
1250 Sw Veterans Way Ste 120, Redmond, OR 97756 | |
| (541) 923-4462 | |
| Not Available |
| Full Name | Dr Brian J Sullivan |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 1250 Sw Veterans Way Ste 120, Redmond, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306088943 | NPI | - | NPPES |
| 500740526 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 257372 (Massachusetts) | Secondary |
| 207Q00000X | Family Medicine | MD186677 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Charles Medical Center - Bend | Bend, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mosaic Community Health | 5395653497 | 49 |
| Mosaic Community Health | 5395653497 | 49 |
News Archive
University of Michigan scientists report highly encouraging evidence that a super-fine oil-and-water emulsion, already shown to kill many other microbes, may be able to quell the ravaging, often drug-resistant infections that cause nearly all cystic fibrosis deaths.
Computer algorithms can automatically interpret echocardiographic images and distinguish between pathological hypertrophic cardiomyopathy and physiological changes in athletes' hearts, according to research from the Icahn School of Medicine at Mount Sinai, published online yesterday in the Journal of the American College of Cardiology.
MDX-1303 was developed by Medarex using its UltiMAb Human Antibody Development System, and this antibody is currently in preclinical development by Medarex for use against human anthrax infection.
Human blood is a precious resource. Because stored blood has a very limited shelf life, keeping every available unit of it suitable for medical use is a crucial function at hospitals and other health care facilities - especially during supply shortages such as those currently being experienced in the Triad, other parts of North Carolina and numerous sections of the country.
Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease and kidney disease, according to a new study by rheumatology researchers at Hospital for Special Surgery. The study appears online ahead of print, in the journal Arthritis and Rheumatism.
› Verified 8 days ago
| Entity Name | Edward M Kennedy Community Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609842152 PECOS PAC ID: 3476512740 Enrollment ID: O20041004000840 |
News Archive
University of Michigan scientists report highly encouraging evidence that a super-fine oil-and-water emulsion, already shown to kill many other microbes, may be able to quell the ravaging, often drug-resistant infections that cause nearly all cystic fibrosis deaths.
Computer algorithms can automatically interpret echocardiographic images and distinguish between pathological hypertrophic cardiomyopathy and physiological changes in athletes' hearts, according to research from the Icahn School of Medicine at Mount Sinai, published online yesterday in the Journal of the American College of Cardiology.
MDX-1303 was developed by Medarex using its UltiMAb Human Antibody Development System, and this antibody is currently in preclinical development by Medarex for use against human anthrax infection.
Human blood is a precious resource. Because stored blood has a very limited shelf life, keeping every available unit of it suitable for medical use is a crucial function at hospitals and other health care facilities - especially during supply shortages such as those currently being experienced in the Triad, other parts of North Carolina and numerous sections of the country.
Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease and kidney disease, according to a new study by rheumatology researchers at Hospital for Special Surgery. The study appears online ahead of print, in the journal Arthritis and Rheumatism.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian J Sullivan, MD 600 Sw Columbia St Ste 6210, Bend, OR 97702-1099 Ph: (541) 383-3005 | Dr Brian J Sullivan, MD 1250 Sw Veterans Way Ste 120, Redmond, OR 97756 Ph: (541) 923-4462 |
News Archive
University of Michigan scientists report highly encouraging evidence that a super-fine oil-and-water emulsion, already shown to kill many other microbes, may be able to quell the ravaging, often drug-resistant infections that cause nearly all cystic fibrosis deaths.
Computer algorithms can automatically interpret echocardiographic images and distinguish between pathological hypertrophic cardiomyopathy and physiological changes in athletes' hearts, according to research from the Icahn School of Medicine at Mount Sinai, published online yesterday in the Journal of the American College of Cardiology.
MDX-1303 was developed by Medarex using its UltiMAb Human Antibody Development System, and this antibody is currently in preclinical development by Medarex for use against human anthrax infection.
Human blood is a precious resource. Because stored blood has a very limited shelf life, keeping every available unit of it suitable for medical use is a crucial function at hospitals and other health care facilities - especially during supply shortages such as those currently being experienced in the Triad, other parts of North Carolina and numerous sections of the country.
Rituximab, a drug used to treat cancer and arthritis, may help patients with antiphospholipid antibodies (aPLs) who suffer from aPL-related clinical problems that do not respond to anticoagulation, such as cardiac disease and kidney disease, according to a new study by rheumatology researchers at Hospital for Special Surgery. The study appears online ahead of print, in the journal Arthritis and Rheumatism.
› Verified 8 days ago
Dr. Alan C Hilles, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 865 Sw Veterans Way, Redmond, OR 97756 Phone: 541-322-3500 | |
Nathan R Thompson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 Nw Larch Ave, Redmond, OR 97756 Phone: 541-548-2164 Fax: 541-548-0534 | |
Sheryl L Norris, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 211 Nw Larch Ave, Redmond, OR 97756 Phone: 541-548-2164 Fax: 541-548-0534 | |
James K Detwiler, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 211 Nw Larch Ave, Redmond, OR 97756 Phone: 541-548-2164 Fax: 541-548-0534 | |
Rose J Kenny, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1001 Nw Canal Blvd Ste 101, Redmond, OR 97756 Phone: 541-548-8088 Fax: 541-548-8018 | |
Dr. Christopher Schuler, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 Nw Larch Ave, Redmond, OR 97756 Phone: 541-548-2164 Fax: 541-548-0534 | |
Pamela J Irby, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 Nw Larch Ave, Redmond, OR 97756 Phone: 541-548-2164 Fax: 541-548-0534 |